Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β -microglobulin yields a more accurate GELTAMO-IPI.

Br J Haematol 2017 03 20;176(6):918-928. Epub 2017 Jan 20.

Department of Translational Research, MD Anderson Cancer Centre, Madrid, Spain.

The study included 1848 diffuse large B-cell lymphoma (DLBCL)patients treated with chemotherapy/rituximab. The aims were to validate the National Comprehensive Cancer Network International Prognostic Index (NCCN-IPI) and explore the effect of adding high Beta-2 microglobulin (β2M), primary extranodal presentation and intense treatment to the NCCN-IPI variables in order to develop an improved index. Comparing survival curves, NCCN-IPI discriminated better than IPI, separating four risk groups with 5-year overall survival rates of 93%, 83%, 67% and 49%, but failing to identify a true high-risk population. For the second aim the series was split into training and validation cohorts: in the former the multivariate model identified age, lactate dehydrogenase, Eastern Cooperative Oncology Group performance status, Stage III-IV, and β2M as independently significant, whereas the NCCN-IPI-selected extranodal sites, primary extranodal presentation and intense treatments were not. These results were confirmed in the validation cohort. The Grupo Español de Linfomas/Trasplante de Médula ósea (GELTAMO)-IPI developed here, with 7 points, significantly separated four risk groups (0, 1-3, 4 or ≥5 points) with 11%, 58%, 17% and 14% of patients, and 5-year overall survival rates of 93%, 79%, 66% and 39%, respectively. In the comparison GELTAMO IPI discriminated better than the NCCN-IPI. In conclusion, GELTAMO-IPI is more accurate than the NCCN-IPI and has statistical and practical advantages in that the better discrimination identifies an authentic high-risk group and is not influenced by primary extranodal presentation or treatments of different intensity.

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14489DOI Listing
March 2017
51 Reads

Publication Analysis

Top Keywords

extranodal presentation
12
primary extranodal
12
large b-cell
8
survival rates
8
rates 93%
8
5-year survival
8
b-cell lymphoma
8
diffuse large
8
discriminated better
8
risk groups
8
presentation intense
8
nccn-ipi
5
cooperative oncology
4
oncology group
4
eastern cooperative
4
dehydrogenase eastern
4
lactate dehydrogenase
4
group performance
4
age lactate
4
independently nccn-ipi-selected
4

References

(Supplied by CrossRef)

Cleves et al.
2008

Jaffe et al.
2001

Similar Publications